TY  - GEN
AU  - Fricke,W
TI  - FDA perspective on and response to the risk of hepatitis A from blood products
SN  - 0042-9007
PY  - 1995///0223
KW  - Blood Coagulation Factors
KW  - adverse effects
KW  - Databases, Factual
KW  - Detergents
KW  - Disease Outbreaks
KW  - Drug Contamination
KW  - Europe
KW  - epidemiology
KW  - Hepatitis A
KW  - Humans
KW  - Parvoviridae Infections
KW  - Risk
KW  - Safety
KW  - Solvents
KW  - United States
KW  - United States Food and Drug Administration
N1  - Publication Type: Journal Article; Review
ER  -